Polyphenols intervention is an effective strategy to ameliorate inflammatory bowel disease: a systematic review and meta-analysis

References

• Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. 2013. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology. 145(5):970–977.
   PubMed Web of Science ®Google Scholar
• Banerjee R, Penmetsa A, Medaboina K, Boramma GG, Amsrala S, Reddy DN. 2017. Novel bio-enhanced curcumin with mesalamine for induction of remission in mild to moderate ulcerative colitis. Gastroenterology. 152(5):S587.
   Web of Science ®Google Scholar
• Chandel S, Prakash A, Medhi B. 2015. Current scenario in inflammatory bowel disease: drug development prospects. Pharmacol Rep. 67(2):224–229.
   PubMed Web of Science ®Google Scholar
• Clark HD, Wells GA, Huet C, McAlister FA, Salmi LR, Fergusson D, Laupacis A. 1999. Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials. 20(5):448–452.
   PubMedGoogle Scholar
• D’Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R. 2007. Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita. 43(4):348–361.
   PubMedGoogle Scholar
• Denis MC, Roy D, Yeganeh PR, Desjardins Y, Varin T, Haddad N, Amre D, Sane AT, Garofalo C, Furtos A, et al. 2016. Apple peel polyphenols: a key player in the prevention and treatment of experimental inflammatory bowel disease. Clin Sci (Lond). 130(23):2217–2237.
   PubMed Web of Science ®Google Scholar
• Dryden GW, Lam A, Beatty K, Qazzaz HH, McClain CJ. 2013. A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis. Inflamm Bowel Dis. 19(9):1904–1912.
   PubMed Web of Science ®Google Scholar
• Etxeberria U, Fernandez-Quintela A, Milagro FI, Aguirre L, Martinez JA, Portillo MP. 2013. Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J Agric Food Chem. 61(40):9517–9533.
   PubMed Web of Science ®Google Scholar
• Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. 2014. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res. 34(10):837–843.
   PubMed Web of Science ®Google Scholar
• Farhat G, Drummond S, Al-Dujaili EAS. 2017. Polyphenols and their role in obesity management: a systematic review of randomized clinical trials. Phytother Res. 31(7):1005–1018.
   PubMed Web of Science ®Google Scholar
• Gajendran M, Loganathan P, Catinella AP, Hashash JG. 2018. A comprehensive review and update on Crohn’s disease. Disease-a-Month: DM. 64(2):20–57.
   PubMed Web of Science ®Google Scholar
• Grosso G, Godos J, Lamuela-Raventos R, Ray S, Micek A, Pajak A, Sciacca S, D’Orazio N, Del Rio D, Galvano F. 2017. A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: Level of evidence and limitations. Mol Nutr Food Res. 61(4). DOI:10.1002/mnfr.201600930
   PubMed Web of Science ®Google Scholar
• Gupta SK. 2011. Intention-to-treat concept: a review. Perspect Clin Res. 2(3):109–112.
   PubMedGoogle Scholar
• Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, Tsujikawa T, Fujiyama Y, Mitsuyama K, Sata M, et al. 2006. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 4(12):1502–1506.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ (Clinical Research ed). 327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Holleran G, Lopetuso L, Petito V, Graziani C, Ianiro G, McNamara D, Gasbarrini A, Scaldaferri F. 2017. The innate and adaptive immune system as targets for biologic therapies in inflammatory bowel disease. IJMS. 18(10):2020.
   Google Scholar
• Holleran G, Scaldaferri F, Gasbarrini A, Curro D. 2020. Herbal medicinal products for inflammatory bowel disease: a focus on those assessed in double-blind randomised controlled trials. Phytother Res. 34(1):77–93.
   PubMed Web of Science ®Google Scholar
• Hou JK, Abraham B, El-Serag H. 2011. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 106(4):563–573.
   PubMed Web of Science ®Google Scholar
• Kaulmann A, Bohn T. 2016. Bioactivity of polyphenols: preventive and adjuvant strategies toward reducing inflammatory bowel diseases-promises, perspectives, and pitfalls. Oxid Med Cell Longev. 2016:1–29.
   Web of Science ®Google Scholar
• Kedia S, Bhatia V, Thareja S, Garg S, Mouli VP, Bopanna S, Tiwari V, Makharia G, Ahuja V. 2017. Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: results from a randomized double blind placebo controlled trial. WJGPT. 8(2):147–154.
   Google Scholar
• Kumar S, Dutta U, Shah J, Singh P, Vaishnavi C, Prasad KK, Singh K. 2019. Impact of curcuma long a on clinical activity and inflammatory markers in patients with active ulcerative colitis: a double-blind randomised placebo-controlled trial. J Crohn’s Colitis. 13(Supplement_1):S322–S323.
   Google Scholar
• Lang A, Salomon N, Wu JC, Kopylov U, Lahat A, Har-Noy O, Ching JY, Cheong PK, Avidan B, Gamus D, et al. 2015. Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol Hepatol. 13(8):1444–1449.
   PubMed Web of Science ®Google Scholar
• Le Sage F, Meilhac O, Gonthier MP. 2017. Anti-inflammatory and antioxidant effects of polyphenols extracted from Antirhea borbonica medicinal plant on adipocytes exposed to Porphyromonas gingivalis and Escherichia coli lipopolysaccharides. Pharmacol Res. 119:303–312.
   PubMed Web of Science ®Google Scholar
• Lu Y-y, Liang J, Chen S-X, Wang B-x, Yuan H, Li C-t, Wu Y-y, Wu Y-f, Shi X-g, Gao J, et al. 2018. Phloridzin alleviate colitis in mice by protecting the intestinal brush border and improving the expression of sodium glycogen transporter 1. J Funct Foods. 45:348–354.
   Web of Science ®Google Scholar
• Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. 2004. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 79(5):727–747.
   PubMed Web of Science ®Google Scholar
• Masoodi M, Mahdiabadi MA, Mokhtare M, Agah S, Kashani AHF, Rezadoost AM, Sabzikarian M, Talebi A, Sahebkar A. 2018. The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients’ self-reported well-being: a randomized double-blind controlled trial. J Cell Biochem. 119(11):9552–9559.
   PubMed Web of Science ®Google Scholar
• Matilde Sanchez M, Chen X. 2006. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat. Statist Med. 25(7):1169–1181.
   PubMed Web of Science ®Google Scholar
• McCormick F, Cvetanovich GL, Kim JM, Harris JD, Gupta AK, Abrams GD, Romeo AA, Provencher MT. 2013. An assessment of the quality of rotator cuff randomized controlled trials: utilizing the Jadad score and CONSORT criteria. J Shoulder Elb Surg. 22(9):1180–1185.
   PubMed Web of Science ®Google Scholar
• McDaniel DK, Eden K, Ringel VM, Allen IC. 2016. Emerging roles for noncanonical NF-κB signaling in the modulation of inflammatory bowel disease pathobiology. Inflamm Bowel Dis. 22(9):2265–2279.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 62(10):1006–1012.
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et al. 2017. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 390(10114):2769–2778.
   PubMed Web of Science ®Google Scholar
• Nikkhah-Bodaghi M, Darabi Z, Agah S, Hekmatdoost A. 2019a. The effects of Nigella sativa on quality of life, disease activity index, and some of inflammatory and oxidative stress factors in patients with ulcerative colitis. Phytother Res. 33(4):1027–1032.
   PubMed Web of Science ®Google Scholar
• Nikkhah-Bodaghi M, Maleki I, Agah S, Hekmatdoost A. 2019b. Zingiber officinale and oxidative stress in patients with ulcerative colitis: a randomized, placebo-controlled, clinical trial. Complement Ther Med. 43:1–6.
   PubMed Web of Science ®Google Scholar
• Nunes S, Danesi F, Del Rio D, Silva P. 2018. Resveratrol and inflammatory bowel disease: the evidence so far. Nutr Res Rev. 31(1):85–97.
   PubMed Web of Science ®Google Scholar
• Panahande SB, Maghbooli Z, Hossein-Nezhad A, Qorbani M, Moeini-Nodeh S, Haghi-Aminjan H, Hosseini S. 2019. Effects of French maritime pine bark extract (Oligopin(R)) supplementation on bone remodeling markers in postmenopausal osteopenic women: a randomized clinical trial. Phytother Res. 33(4):1233–1240.
   PubMed Web of Science ®Google Scholar
• Podolsky DK. 2002. Inflammatory bowel disease. N Engl J Med. 347(6):417–429.
   PubMed Web of Science ®Google Scholar
• Rahimi R, Nikfar S, Rezaie A, Abdollahi M. 2008. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol. 25(2):271–275.
   PubMed Web of Science ®Google Scholar
• Ranganathan P, Pramesh CS, Aggarwal R. 2016. Common pitfalls in statistical analysis: Intention-to-treat versus per-protocol analysis. Perspect Clin Res. 7(3):144–146.
   PubMedGoogle Scholar
• Rastegarpanah M, Malekzadeh R, Vahedi H, Mohammadi M, Elahi E, Chaharmahali M, Safarnavadeh T, Abdollahi M. 2015. A randomized, double blinded, placebo-controlled clinical trial of silymarin in ulcerative colitis. Chin J Integr Med. 21(12):902–906.
   PubMed Web of Science ®Google Scholar
• Restellini S, Chazouilleres O, Frossard JL. 2017. Hepatic manifestations of inflammatory bowel diseases. Liver Int. 37(4):475–489.
   PubMed Web of Science ®Google Scholar
• Rubin DC, Shaker A, Levin MS. 2012. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immun. 3:107.
   PubMed Web of Science ®Google Scholar
• Salari-Sharif P, Abdollahi M. 2010. Phosphodiesterase 4 inhibitors in inflammatory bowel disease: a comprehensive review. CPD. 16(33):3661–3667.
   Google Scholar
• Samsami-Kor M, Daryani NE, Asl PR, Hekmatdoost A. 2015. Anti-inflammatory effects of resveratrol in patients with ulcerative colitis: a randomized, double-blind, placebo-controlled pilot study. Arch Med Res. 46(4):280–285.
   PubMed Web of Science ®Google Scholar
• Samsamikor M, Daryani NE, Asl PR, Hekmatdoost A. 2016. Resveratrol supplementation and oxidative/anti-oxidative status in patients with ulcerative colitis: a randomized, double-blind, placebo-controlled pilot study. Arch Med Res. 47(4):304–309.
   PubMed Web of Science ®Google Scholar
• Sanchez-Rodriguez C, Martin-Sanz E, Cuadrado E, Granizo JJ, Sanz-Fernandez R. 2016. Protective effect of polyphenols on presbycusis via oxidative/nitrosative stress suppression in rats. Exp Gerontol. 83:31–36.
   PubMed Web of Science ®Google Scholar
• Santangelo C, Vari R, Scazzocchio B, Di Benedetto R, Filesi C, Masella R. 2007. Polyphenols, intracellular signalling and inflammation. Annali Dell’Istituto Superiore di Sanita. 43(4):394–405.
   PubMedGoogle Scholar
• Sasaki M, Nishida N, Shimada M. 2018. A beneficial role of rooibos in diabetes mellitus: a systematic review and meta-analysis. Molecules. 23(4):839.
   Web of Science ®Google Scholar
• Scaioli E, Belluzzi A, Ricciardiello L, Del Rio D, Rotondo E, Mena P, Derlindati E, Danesi F. 2019. Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: study protocol for a randomized controlled trial. Trials. 20(1):327.
   PubMedGoogle Scholar
• Singla V, Pratap Mouli V, Garg SK, Rai T, Choudhury BN, Verma P, Deb R, Tiwari V, Rohatgi S, Dhingra R, et al. 2014. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study. J Crohn’s Colitis. 8(3):208–214.
   Google Scholar
• Sugimoto K, Ikeya K, Bamba S, Andoh A, Yamasaki H, Mitsuyama K, Nasuno M, Tanaka H, Matsuura A, Kato M, et al. 2019. Bioavailable curcumin (Theracurmin®) for Crohn’s disease: randomized, multicenter, double-blind, placebo-controlled trial. Gastroenterology. 156(6):S-1096.
   Web of Science ®Google Scholar
• Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. 2017. Ulcerative colitis. Lancet. 389(10080):1756–1770.
   PubMed Web of Science ®Google Scholar
• Walldorf J, Krummenerl A, Engler K, Busch J, Dollinger MM, Seufferlein T, Albert JG. 2013. Health care for osteoporosis in inflammatory bowel disease: unmet needs in care of male patients. J Crohn’s Colitis. 7(11):901–907.
   Google Scholar
• Wang X, Ouyang YY, Liu J, Zhao G. 2014. Flavonoid intake and risk of CVD: a systematic review and meta-analysis of prospective cohort studies. Br J Nutr. 111(1):1–11.
   PubMed Web of Science ®Google Scholar
• Weimers P, Munkholm P. 2018. The natural history of IBD: lessons learned. Curr Treat Options Gastro. 16(1):101–111.
   PubMedGoogle Scholar
• Wu S, Hu R, Nakano H, Chen K, Liu M, He X, Zhang H, He J, Hou DX. 2018. Modulation of gut microbiota by Lonicera caerulea L. berry polyphenols in a mouse model of fatty liver induced by high fat diet. Molecules (Basel, Switzerland). 23(12):3213.
   Web of Science ®Google Scholar
• Yildiz G, Yildiz Y, Ulutas PA, Yaylali A, Ural M. 2015. Resveratrol pretreatment ameliorates TNBS colitis in rats. EMI. 9(2):134–140.
   Google Scholar
• Zhang L, Xue H, Zhao G, Qiao C, Sun X, Pang C, Zhang D. 2019. Curcumin and resveratrol suppress dextran sulfate sodiuminduced colitis in mice. Mol Med Rep. 19(4):3053–3060.
   PubMed Web of Science ®Google Scholar
• Zhao H, Cheng N, Zhou W, Chen S, Wang Q, Gao H, Xue X, Wu L, Cao W. 2019. Honey polyphenols ameliorate DSS-induced ulcerative colitis via modulating gut microbiota in rats. Mol Nutr Food Res. 63(23):e1900638.
   PubMed Web of Science ®Google Scholar